120 related articles for article (PubMed ID: 8474319)
21. Metabolic abnormalities in the genetically obese and diabetic Otsuka Long-Evans Tokushima Fatty rat can be prevented and reversed by alpha-glucosidase inhibitor.
Yamamoto M; Jia DM; Fukumitsu KI; Imoto I; Kihara Y; Hirohata Y; Otsuki M
Metabolism; 1999 Mar; 48(3):347-54. PubMed ID: 10094112
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of myocardial lesions in the JCR:LA-corpulent rat by captopril.
Russell JC; Graham SE; Amy RM; Dolphin PJ
J Cardiovasc Pharmacol; 1998 Jun; 31(6):971-7. PubMed ID: 9641485
[TBL] [Abstract][Full Text] [Related]
23. Glucose tolerance and insulin resistance in the JCR:LA-corpulent rat: effect of miglitol (Bay m1099).
Russell JC; Graham SE; Dolphin PJ
Metabolism; 1999 Jun; 48(6):701-6. PubMed ID: 10381143
[TBL] [Abstract][Full Text] [Related]
24. Sustained decreases in weight and serum insulin, glucose, triacylglycerol and cholesterol in JCR:LA-corpulent rats treated with D-fenfluramine.
Brindley DN; Hales P; al-Sieni AI; Russell JC
Br J Pharmacol; 1992 Mar; 105(3):679-85. PubMed ID: 1628154
[TBL] [Abstract][Full Text] [Related]
25. Myocardial disease and catecholamine metabolism in JCR:LA-corpulent rat.
Russell JC; Koeslag DG; Amy RM; Dolphin PJ
Exp Mol Pathol; 1991 Feb; 54(1):31-40. PubMed ID: 1899832
[TBL] [Abstract][Full Text] [Related]
26. Fibrinolysis and atherogenesis in the JCR:LA-cp rat in relation to insulin and triglyceride concentrations in blood.
Schneider DJ; Absher PM; Neimane D; Russell JC; Sobel BE
Diabetologia; 1998 Feb; 41(2):141-7. PubMed ID: 9498646
[TBL] [Abstract][Full Text] [Related]
27. Influence of acarbose (a glucosidase inhibitor) on experimental atherosclerosis in the rabbit.
Kritchevsky D; Tepper SA; Davidson LM; Klurfeld DM
Artery; 1990; 17(3):170-5. PubMed ID: 2186716
[TBL] [Abstract][Full Text] [Related]
28. Effects of chronic treatment with acarbose on glucose and lipid metabolism in obese diabetic Wistar rats.
Carrascosa JM; Molero JC; Fermín Y; Martínez C; Andrés A; Satrústegui J
Diabetes Obes Metab; 2001 Aug; 3(4):240-8. PubMed ID: 11520303
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of alpha-glucosidase inhibitors on lipids in NIDDM subjects with moderate hyperlipidaemia.
Leonhardt W; Hanefeld M; Fischer S; Schulze J
Eur J Clin Invest; 1994 Aug; 24 Suppl 3():45-9. PubMed ID: 8001628
[TBL] [Abstract][Full Text] [Related]
30. Acarbose reduces blood pressure in sucrose-induced hypertension in rats.
Madar Z; Melamed EC; Zimlichman R
Isr J Med Sci; 1997 Mar; 33(3):153-9. PubMed ID: 9313782
[TBL] [Abstract][Full Text] [Related]
31. Increased hepatic VLDL secretion, lipogenesis, and SREBP-1 expression in the corpulent JCR:LA-cp rat.
Elam MB; Wilcox HG; Cagen LM; Deng X; Raghow R; Kumar P; Heimberg M; Russell JC
J Lipid Res; 2001 Dec; 42(12):2039-48. PubMed ID: 11734577
[TBL] [Abstract][Full Text] [Related]
32. The retardation of vasculopathy induced by attenuation of insulin resistance in the corpulent JCR:LA-cp rat is reflected by decreased vascular smooth muscle cell proliferation in vivo.
Absher PM; Schneider DJ; Baldor LC; Russell JC; Sobel BE
Atherosclerosis; 1999 Apr; 143(2):245-51. PubMed ID: 10217352
[TBL] [Abstract][Full Text] [Related]
33. Beneficial effects of acarbose on daily plasma glucose profile and cataract development in sand rats.
Madar Z; Hazan A; Pollack A
Eye (Lond); 1994; 8 ( Pt 3)():353-6. PubMed ID: 7958047
[TBL] [Abstract][Full Text] [Related]
34. Sexual dimorphism in the metabolic response to the calcium channel antagonists, diltiazem and clentiazem, by hyperlipidemic JCR:LA-cp rats.
Russell JC; Graham SE; Stewart B; Dolphin PJ
Biochim Biophys Acta; 1995 Sep; 1258(2):199-205. PubMed ID: 7548184
[TBL] [Abstract][Full Text] [Related]
35. Comparison of the enteroinsular axis in two strains of obese rat, the fatty Zucker and the JCR:LA-corpulent.
Pederson RA; Campos RV; Buchan AM; Chisholm CB; Russell JC; Brown JC
Int J Obes; 1991 Jul; 15(7):461-70. PubMed ID: 1894423
[TBL] [Abstract][Full Text] [Related]
36. Acarbose treatment and diabetic nephropathy in the Cohen diabetic rat.
Cohen AM; Rosenmann E
Horm Metab Res; 1990 Oct; 22(10):511-5. PubMed ID: 2079312
[TBL] [Abstract][Full Text] [Related]
37. Oral chromium picolinate improves carbohydrate and lipid metabolism and enhances skeletal muscle Glut-4 translocation in obese, hyperinsulinemic (JCR-LA corpulent) rats.
Cefalu WT; Wang ZQ; Zhang XH; Baldor LC; Russell JC
J Nutr; 2002 Jun; 132(6):1107-14. PubMed ID: 12042418
[TBL] [Abstract][Full Text] [Related]
38. Metabolic abnormalities linked to obesity: effects of dexfenfluramine in the corpulent rat.
Brindley DN; Russell JC
Metabolism; 1995 Feb; 44(2 Suppl 2):23-7. PubMed ID: 7869933
[TBL] [Abstract][Full Text] [Related]
39. Development and characteristics of a new strain of obese hyperinsulinemic and hyperlipidemic Dahl salt-sensitive rat. The Dahl salt-sensitive/NIH-corpulent rat.
Michaelis OE; Velasquez MT; Abraham AA; Servetnick DA; Scholfield DJ; Hansen CT
Am J Hypertens; 1995 May; 8(5 Pt 1):467-73. PubMed ID: 7662222
[TBL] [Abstract][Full Text] [Related]
40. Chylomicron and apoB48 metabolism in the JCR:LA corpulent rat, a model for the metabolic syndrome.
Mangat R; Su J; Scott PG; Russell JC; Vine DF; Proctor SD
Biochem Soc Trans; 2007 Jun; 35(Pt 3):477-81. PubMed ID: 17511632
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
